shutterstock_596091488_1000_words
1000 words / Shutterstock.com
25 September 2019EuropeRory O'Neill

UK Labour promises public generics company, compulsory drug licensing

Jeremy Corbyn, leader of the UK Labour Party, has pledged to create a publicly-owned drugs manufacturer and use compulsory licensing to sell generic, lower priced versions of drugs to the country’s National Health Service (NHS).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Generics
26 September 2019   China’s drug pricing overhaul has seen the average cost of drugs drop by more than half, the country’s Joint Procurement Office announced this week.
Generics
19 November 2019   The Russian government has endorsed legislation that would allow it to employ compulsory drug licensing in emergencies.
Big Pharma
1 February 2022   UK politicians are proposing that the country waive UK registered IP related to vaccines and treatments in the event of a pandemic.

More on this story

Generics
26 September 2019   China’s drug pricing overhaul has seen the average cost of drugs drop by more than half, the country’s Joint Procurement Office announced this week.
Generics
19 November 2019   The Russian government has endorsed legislation that would allow it to employ compulsory drug licensing in emergencies.
Big Pharma
1 February 2022   UK politicians are proposing that the country waive UK registered IP related to vaccines and treatments in the event of a pandemic.

More on this story

Generics
26 September 2019   China’s drug pricing overhaul has seen the average cost of drugs drop by more than half, the country’s Joint Procurement Office announced this week.
Generics
19 November 2019   The Russian government has endorsed legislation that would allow it to employ compulsory drug licensing in emergencies.
Big Pharma
1 February 2022   UK politicians are proposing that the country waive UK registered IP related to vaccines and treatments in the event of a pandemic.